7 Israeli robots that are transforming surgery
#ViRob Robotic or robot-assisted surgery can give doctors better vision, precision, flexibility and control when performing complex minimally invasive procedures. Someday, surgeons will even use More...
Dead could be brought ‘back to life’ in groundbreaking project
A biotech company is seeking 20 people who have been declared clinically dead for an attempt to reawaken parts of their central nervous systems. Philadelphia-based Bioquark, Inc. has been granted ethical approval More...
Check Out The New Optic Tech Being Developed in Israel
3Dot The 2016 Business Opportunities in Israel Lasers Electro-Optics conference was held at the Lev Academic Center in Jerusalem last week. A number of startups which use new technologies were represented More...
How much does it hurt? New system quantifies pain at last
Rate your pain on a scale of 1 to 10: Health professionals rely on this subjective method to assess pain. It’s not only imprecise but also impossible in many circumstances, such as when the patient More...
Biotech Company Juno Therapeutics Possibly on George Soros’ Radar
Billionaire investor George Soros may have an interest in Juno Therapeutics, an immunotherapy stock that had its IPO last Friday, multimedia financial services company The Motley Fool said. As of the end More...
Why Jim Cramer Is Staying Away from Biotechs
Jim Cramer on his CNBC Mad Money program was bullish on biotechs all summer. This was after a surplus of biotech IPOs flooded the market in the spring, and the sector bottomed. Biotechs rebounded with a vengeance More...
George Soros Dumps Biotech
– The biotech sector has been outperforming the S&P 500, and some money managers continue to buy even as others are concerned about a bubble, as reported by Motley Fool. The iShares More...
Exclusive: First gene therapy drug sets million-euro price record
– The Western world’s first gene therapy drug is set to go on sale in Germany with a 1.1 million euro ($1.4 million) price tag, a new record for a medicine to treat a rare disease. The More...
Jim Cramer: Biotech, Housing and Cult Stocks Driving Market
On his Tuesday, November 11th episode of Mad Money on CNBC, Cramer identified 3 sectors that are leading stocks: Biotech, Housing and “Cult Stocks.” Regeneron was the surprise driver of biotech. More...
Clal Biotech Sells Pidilizumab Cancer Treatment Rights to Medivation
Israel’s Clal Biotechnology Industries has sold the exclusive worldwide commercialization rights for its cancer treatment pidilizumab to the American company Medivation. The rights are held by Clal subsidiary More...